The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
N Cresto, C Gardier, F Gubinelli… - European Journal of …, 2019 - Wiley Online Library
Our understanding of the mechanisms underlying Parkinson's disease, the once
archetypical nongenetic neurogenerative disorder, has dramatically increased with the …
archetypical nongenetic neurogenerative disorder, has dramatically increased with the …
[HTML][HTML] Recent advances in the neuroprotective effects of medical gases
YZ Wang, TT Li, HL Cao, WC Yang - Medical gas research, 2019 - journals.lww.com
Central nervous system injuries are a leading cause of death and disability worldwide.
Although the exact pathophysiological mechanisms of various brain injuries vary, central …
Although the exact pathophysiological mechanisms of various brain injuries vary, central …
[HTML][HTML] Effect of LRRK2 G2385R variant on subthalamic deep brain stimulation efficacy in Parkinson's disease in a Han Chinese population
S Chen, H Liu, Q Wu, S Xu, W Li, T Chen, C Li… - Frontiers in …, 2019 - frontiersin.org
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for
advanced Parkinson's disease (PD). The G2385R variant of LRRK2 is a risk factor for PD in …
advanced Parkinson's disease (PD). The G2385R variant of LRRK2 is a risk factor for PD in …
[PDF][PDF] 动物分子影像技术在帕金森病诊断研究中的运用
涂清强， 李红宇 - 中国比较医学杂志, 2019 - zgbjyx.cnjournals.com
帕金森病(Parkinson's disease, PD) 是一种神经退行性疾病, 在中老年群体中较为常见,
危害性大, 但是早期临床诊断与鉴别帕金森病, 帕金森叠加综合征以及其他运动障碍性疾病有 …
危害性大, 但是早期临床诊断与鉴别帕金森病, 帕金森叠加综合征以及其他运动障碍性疾病有 …